According to ChemAnalyst, The Amphotericin B Prices recorded a marginal upward movement during the second quarter of 2026, with prices increasing across North America, Asia-Pacific (APAC), and Europe. The relatively small quarter-over-quarter gains indicate a broadly stable market, while producers and suppliers continued to manage higher operating, logistics, compliance, and energy-related expenses.

During Q2 2026, the Amphotericin B Price Index in the United States increased by 0.27% quarter-over-quarter, while China and Germany registered increases of 0.26% each. Although the changes were limited, they reflected continued cost pass-through throughout the pharmaceutical supply chain. Manufacturing expenses, regulatory requirements, transportation costs, energy prices, and supplier offers remained important factors influencing the quarterly pricing environment.

The average Amphotericin B price in the United States was approximately USD 651,896.67/MT, while the average price in China reached around USD 651,666.67/MT FOB Shanghai. In Germany, the average Amphotericin B price was approximately USD 651,810/MT CFR Hamburg.

The Q2 2026 market therefore remained relatively balanced, with no major demand shock or supply disruption significantly altering price levels. However, the modest increases demonstrate that producers continued to pass selected cost pressures through to buyers.

Amphotericin B Prices in North America

In the United States, the Amphotericin B Price Index increased by 0.27% quarter-over-quarter during Q2 2026. The increase was marginal but reflected a combination of manufacturing expenses, logistics costs, quality-control requirements, and compliance-related expenditures.

The average Amphotericin B price in the United States was approximately USD 651,896.67/MT during the quarter. The pricing environment remained relatively stable as pharmaceutical buyers maintained regular procurement schedules while suppliers focused on preserving margins amid higher input and operational costs.

Amphotericin B is a specialized antifungal active pharmaceutical ingredient (API), and its production involves stringent quality-control and regulatory requirements. Consequently, pricing is influenced not only by basic production costs but also by testing, documentation, manufacturing controls, storage, and compliance expenses.

During Q2, logistics costs also contributed to the marginal increase in prices. Pharmaceutical supply chains require controlled handling, reliable transportation, and appropriate storage conditions. Any increase in freight or associated distribution expenses can gradually influence delivered pricing.

Demand from pharmaceutical manufacturers and healthcare-related applications provided a stable foundation for the market. However, buyers continued to maintain disciplined procurement strategies, limiting the possibility of a sharp price increase.

Overall, the North American Amphotericin B market remained balanced during Q2 2026. The 0.27% increase in the price index indicates that cost pressures were present but remained relatively contained.

Get Real Time Online for Amphotericin B Prices: https://www.chemanalyst.com/Pricing-data/amphotericin-b-1447

Amphotericin B Prices in APAC

The Asia-Pacific region continued to play an important role in the global Amphotericin B supply chain during Q2 2026. In China, the Amphotericin B Price Index increased by 0.26% quarter-over-quarter, indicating a marginal strengthening in market prices.

The average Amphotericin B price in China was approximately USD 651,666.67/MT based on FOB Shanghai assessments.

The Chinese market experienced modest cost pass-through during the quarter. Producers faced ongoing expenses related to manufacturing, quality assurance, energy consumption, labor, and pharmaceutical compliance. These factors supported a slight upward adjustment in offers.

China's position as a major pharmaceutical manufacturing and export hub also means that FOB pricing can be influenced by international procurement activity, shipping costs, currency movements, and export demand. During Q2 2026, however, these factors did not generate a major market imbalance.

Demand remained relatively stable from pharmaceutical manufacturers and distributors. Buyers continued to monitor inventory levels carefully, while suppliers adjusted offers gradually rather than implementing significant price increases.

The limited 0.26% quarterly increase suggests that the APAC market remained fundamentally balanced. Supply availability was sufficient to meet prevailing demand, while producers were able to recover part of their increased operating costs through pricing.

The Chinese Amphotericin B market therefore entered the second half of 2026 with a stable pricing structure and limited short-term volatility.

Amphotericin B Prices in Europe

European Amphotericin B prices also recorded a marginal increase during Q2 2026. In Germany, the Amphotericin B Price Index increased by 0.26% quarter-over-quarter, supported primarily by energy-related expenses and supplier offers.

The average Amphotericin B price in Germany reached approximately USD 651,810/MT on a CFR Hamburg basis.

Germany's pharmaceutical industry operates under stringent quality and regulatory standards, which can contribute to higher production, testing, documentation, and compliance costs. Energy prices are another important consideration for pharmaceutical manufacturing because production and associated processing activities require reliable energy supplies.

During Q2 2026, energy-related expenses contributed to the gradual upward pressure on supplier offers. However, the increase remained modest because demand conditions did not demonstrate a substantial acceleration.

Import and transportation considerations also affected CFR Hamburg pricing. Freight, insurance, port handling, and other logistics-related expenses can influence the delivered cost of pharmaceutical APIs entering Europe.

European buyers remained cautious, focusing on inventory management and procurement efficiency. This restrained purchasing behavior helped prevent a stronger price escalation.

As a result, the German Amphotericin B market remained relatively stable throughout the quarter, with only a modest increase reflecting underlying cost pressures.

Key Factors Influencing Amphotericin B Prices in Q2 2026

Several factors shaped the global Amphotericin B pricing environment during the second quarter of 2026.

Manufacturing Costs

Manufacturing expenses remained one of the fundamental factors supporting the slight increase in Amphotericin B prices. Pharmaceutical APIs require specialized production processes, quality testing, controlled operating environments, and extensive documentation.

Any increase in labor, utilities, maintenance, raw materials, or processing expenses can gradually affect supplier pricing.

Pharmaceutical Compliance Costs

Amphotericin B is used in pharmaceutical applications where quality and consistency are critical. Manufacturers must comply with stringent quality standards and regulatory requirements.

Testing, validation, batch documentation, quality assurance, and regulatory compliance add to the overall cost structure. In Q2 2026, the continued pass-through of these expenses contributed to the marginal increase in regional price indices.

Energy Prices

Energy costs were particularly relevant in the European market. Pharmaceutical manufacturing can be energy-intensive due to processing, purification, temperature control, laboratory operations, and facility requirements.

Higher energy-related expenses can increase the cost base for manufacturers and ultimately influence supplier offers.

Logistics and Freight Costs

Transportation remained another important factor affecting Amphotericin B Prices. Pharmaceutical products and APIs require reliable logistics and controlled supply-chain management.

In North America, logistics and compliance expenses contributed to the slight increase in prices. In Europe, CFR pricing also reflected transportation-related costs associated with deliveries to Hamburg.

Supplier Offers

Supplier pricing strategies played a role in the quarterly movement. Producers sought to protect margins by passing selected cost increases to buyers. However, relatively stable demand limited the ability of suppliers to implement significant price hikes.

Demand from Pharmaceutical Manufacturers

Demand remained an important stabilizing factor. Amphotericin B is a specialized antifungal compound used in pharmaceutical formulations and treatments for serious fungal infections.

Regular procurement requirements supported a stable demand environment, although buyers remained cautious and avoided excessive inventory accumulation.

Global Amphotericin B Price Trend in Q2 2026

The global Amphotericin B price trend during Q2 2026 can be characterized as stable to mildly bullish.

Region	Q2 2026 Price Index Change	Average Price	Basis
United States	+0.27% QoQ	USD 651,896.67/MT	Regional assessment
China	+0.26% QoQ	USD 651,666.67/MT	FOB Shanghai
Germany	+0.26% QoQ	USD 651,810/MT	CFR Hamburg

The narrow difference between regional price movements demonstrates that the market experienced broadly similar cost pressures across major production and consumption regions.

The United States recorded the highest quarterly increase at 0.27%, while China and Germany both increased by 0.26%. This limited variation indicates that there was no major regional divergence in the global market during the quarter.

Supply and Demand Outlook for Amphotericin B

The supply-demand balance remained relatively stable throughout Q2 2026. Producers maintained supply to meet pharmaceutical-sector requirements, while buyers continued to procure according to their production schedules and inventory needs.

On the supply side, manufacturers remained focused on controlling production costs while maintaining quality and regulatory compliance. The specialized nature of Amphotericin B production means that supply cannot always be rapidly expanded in response to short-term changes in demand.

On the demand side, pharmaceutical requirements remained relatively consistent. Healthcare demand for antifungal therapies provided a fundamental base for Amphotericin B consumption, although procurement behavior remained cautious.

This balanced supply-demand structure prevented significant price volatility during the quarter.

Amphotericin B Prices: Regional Comparison

The regional comparison highlights a highly synchronized pricing environment.

The United States recorded an average price of USD 651,896.67/MT, making it the highest among the three reported regional assessments. Germany followed at USD 651,810/MT, while China recorded approximately USD 651,666.67/MT FOB Shanghai.

The price differences were relatively narrow, suggesting that regional cost structures and international market conditions were closely aligned during Q2 2026.

The United States experienced slightly stronger price growth because of marginal logistics and compliance cost pass-through. China benefited from relatively stable supply conditions, while Germany experienced pressure from energy costs and supplier offers.

Amphotericin B Price Forecast

Looking ahead, the Amphotericin B price forecast for the near term indicates a relatively stable market with a potential for modest upward movement if manufacturing, energy, logistics, or compliance costs continue to rise.

The market is unlikely to experience sharp price changes unless there is a significant disruption to production, international logistics, pharmaceutical demand, or raw-material availability.

In North America, continued compliance and logistics expenses could provide modest upward pressure. In China, the market is expected to remain closely linked to manufacturing costs and export demand. In Europe, energy costs and delivered logistics expenses will remain important variables for pricing.

Demand from pharmaceutical manufacturers is expected to provide underlying support to the market. However, disciplined procurement and sufficient supply could limit significant price escalation.

Therefore, the short-term market outlook can be described as stable with a mild upward bias.

Book A Demo for Amphotericin B Prices: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Amphotericin%20B

Conclusion

The global Amphotericin B Prices market experienced a modest increase during the second quarter of 2026. The United States recorded a 0.27% quarter-over-quarter increase, while China and Germany each registered a 0.26% increase.

Average Q2 prices stood at approximately USD 651,896.67/MT in the United States, USD 651,666.67/MT FOB Shanghai in China, and USD 651,810/MT CFR Hamburg in Germany.

The quarterly movement was primarily associated with marginal manufacturing, logistics, energy, supplier, and pharmaceutical compliance costs. Stable demand and adequate supply prevented stronger price escalation.

Going forward, Amphotericin B prices are expected to remain relatively stable, although producers may continue passing higher operating and regulatory costs through to buyers. Monitoring pharmaceutical demand, energy expenses, logistics conditions, supplier offers, and manufacturing economics will remain essential for understanding future Amphotericin B price trends. 

 

 

 

About Us:

Welcome to ChemAnalyst, a next–generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as “Product Innovator of the Year 2023” and ranked among the “Top 100 Digital Procurement Solutions Companies,” we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.

Contact Us:

Address:

420 Lexington Avenue, Suite 300 New York, NY 10170 United States

Phone: +1 332 258 6602

Email: [email protected]

Website: https://www.chemanalyst.com/

LinkedIn: https://www.linkedin.com/company/chemanalyst/

Facebook: https://www.facebook.com/ChemAnalysts/

Twitter: https://x.com/chemanalysts

YouTube: https://www.youtube.com/@chemanalyst

Instagram: https://www.instagram.com/chemanalyst_